ISMP
Survey on Internal and External Medication Error Reporting
(Survey data collected November-December,
2002, and based on respondent's experiences during the year 2002)
Click here
to view article "The reports are in...or are they? Awareness
of medication error reporting programs needs a boost "
Table 1. Respondent Profile (N=319)
|
Profession
|
Percent
of Respondents
|
Level
|
Percent
of Respondents
|
|
Nurse
|
32%
|
Administration
|
16%
|
|
Pharmacist
|
64%
|
Middle Manager
|
48%
|
|
Physician
|
3%
|
Staff Level
|
36%
|
|
Pharmacy technician
|
1%
|
Other
|
<1%
|
Table 2. Percent of Respondents Who Reported 0, 1-5, or >5
Medication Errors/Patient Safety Issues
|
Type
of Error or Other Medication Safety Issue
|
Internal
System-Wide Reporting
|
External
|
Reporting
|
|
|
Program
|
ISMP/USP
Reporting Program
|
FDA
MEDWATCH
|
|
|
0
| 1-5 | >5
|
0
| 1-5 | >5
|
0
| 1-5 | >5
|
|
a. Adverse drug reaction
|
25 |
31 | 44
|
82 |
15 | 03
|
57 |
36 | 07
|
|
b. A hazardous condition that could lead to
error
|
25 |
44 | 31
|
80 |
18 | 02
|
88 |
11 | 01
|
|
c. An error that did not reach the patient
|
20 |
33 | 47
|
88 |
10 | 02
|
95 |
04 | 00
|
|
d. Error that reached a patient but caused
no harm
|
21 |
34 | 44
|
88 |
11 | 02
|
93 |
06 | 00
|
|
e. Error that caused patient harm
|
50 |
35 | 15
|
88 |
10 | 02
|
86 |
14 | 01
|
Table 3: Percent of Respondents Who Felt Motivational Factors Stimulated
Reporting
|
Motivational
Factors
|
Internal
System-Wide Reporting
|
External
|
Reporting
|
|
|
Program
|
ISMP/USP
Reporting Program
|
FDA
MEDWATCH
|
|
|
Yes
| No
|
Yes
| No
|
Yes
| No
|
|
a. My superior mandates that I report
|
71 |
29
|
25 |
75
|
30 |
70
|
|
b. I'm granted amnesty if I report an error
|
49 |
51
|
38 |
62
|
40 |
60
|
|
c. I feel rewarded for reporting
|
53 |
47
|
58 |
42
|
49 |
51
|
|
d. The information is used to enhance safety
|
95 |
05
|
90 |
10
|
89 |
11
|
|
e. I want others to know about the problem
so needless tragedies can be prevented
|
98 |
02
|
91 |
09
|
50 |
50
|
|
f. The reporting program is easy to use
|
72 |
28
|
67 |
33
|
61 |
39
|
|
g. I trust that my name will be kept confidential
|
65 |
35
|
77 |
23
|
71 |
29
|
Table 4. Percent of Respondents Who Witnessed People, Organizations,
or Others Promote Reporting
(Key: F = Frequently; S = Sometimes; N = Never)
|
People,
Organizations, and Other Healthcare Stakeholders
|
Internal
System-Wide Reporting
|
External
|
Reporting
|
|
|
Program
|
ISMP/USP
Reporting Program
|
FDA
MEDWATCH
|
|
|
F
| S | N
|
F
| S | N
|
F
| S | N
|
|
a. Trustees/Senior Leaders
|
30 |
39 | 31
|
17 |
20 | 63
|
11 |
26 | 63
|
|
b. Middle Managers
|
47 |
42 | 11
|
14 |
28 | 57
|
11 |
29 | 60
|
|
c. Risk Manager
|
60 |
22 | 18
|
20 |
22 | 58
|
16 |
25 | 60
|
|
d. Quality Improvement Professional
|
60 |
21 | 18
|
18 |
27 | 55
|
16 |
24 | 60
|
|
e. Patient/Medication Safety Officer
|
57 |
20 | 22
|
20 |
27 | 53
|
16 |
29 | 55
|
|
f. Staff Educators
|
39 |
33 | 27
|
11 |
18 | 71
|
08 |
20 | 72
|
|
g. Professional Licensing Bodies
|
30 |
33 | 37
|
16 |
28 | 56
|
16 |
28 | 56
|
|
h. Professional Organizations
|
50 |
28 | 22
|
39 |
29 | 32
|
35 |
30 | 35
|
|
i. Professional Journals/Newsletters
|
58 |
26 | 16
|
39 |
27 | 35
|
36 |36
| 28
|
|
j. Local/Federal Government
|
22 |
35 | 43
|
10 |
29 | 61
|
10 |
32 | 58
|
|
k. Accrediting Bodies (e.g., JC)
|
62 |
20 | 18
|
34 |
28 | 38
|
35 |
26 | 39
|
|
l. Academic Educators
|
20 |
34 | 46
|
13|
18 | 69
|
13 |
21 | 67
|
|
m. Drug/Medical Product Vendors
|
10|
35 | 55
|
06 |
21 | 72
|
09 |
22 | 70
|